Speaker illustration

Doctor Ralph Hein

Municipal Hospital of Munich, Munich (Germany)

A head-to-head comparison of uniform prasugrel treatment vs. clopidogrel treatment for confirmed responders in acute coronary syndrome patients: results from the randomized TROPICAL-ACS trial

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Oral P2Y12 inhibitors in acute coronary syndromes: are they all equal?

Thumbnail

Diurnal variability of on-treatment platelet reactivity in clopidogrel vs. prasugrel treated acute coronary syndrome patients: a pre-specified TROPICAL-ACS sub-study

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: The role of platelet function in acute coronary syndromes

Thumbnail

De-escalation of antiplatelet therapy after percutaneous coronary intervention in acute coronary syndrome patients: outcome of diabetics in the randomized TROPICAL-ACS trial

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Diabetes-associated coronary artery disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb